Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

908 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis.
Skokowa J, Steinemann D, Katsman-Kuipers JE, Zeidler C, Klimenkova O, Klimiankou M, Unalan M, Kandabarau S, Makaryan V, Beekman R, Behrens K, Stocking C, Obenauer J, Schnittger S, Kohlmann A, Valkhof MG, Hoogenboezem R, Göhring G, Reinhardt D, Schlegelberger B, Stanulla M, Vandenberghe P, Donadieu J, Zwaan CM, Touw IP, van den Heuvel-Eibrink MM, Dale DC, Welte K. Skokowa J, et al. Among authors: reinhardt d. Blood. 2014 Apr 3;123(14):2229-37. doi: 10.1182/blood-2013-11-538025. Epub 2014 Feb 12. Blood. 2014. PMID: 24523240 Free article.
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia.
Hollink IH, van den Heuvel-Eibrink MM, Zimmermann M, Balgobind BV, Arentsen-Peters ST, Alders M, Willasch A, Kaspers GJ, Trka J, Baruchel A, de Graaf SS, Creutzig U, Pieters R, Reinhardt D, Zwaan CM. Hollink IH, et al. Among authors: reinhardt d. Blood. 2009 Jun 4;113(23):5951-60. doi: 10.1182/blood-2008-09-177949. Epub 2009 Jan 26. Blood. 2009. PMID: 19171881 Free article.
High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia.
Luesink M, Hollink IH, van der Velden VH, Knops RH, Boezeman JB, de Haas V, Trka J, Baruchel A, Reinhardt D, van der Reijden BA, van den Heuvel-Eibrink MM, Zwaan CM, Jansen JH. Luesink M, et al. Among authors: reinhardt d. Blood. 2012 Sep 6;120(10):2064-75. doi: 10.1182/blood-2011-12-397083. Epub 2012 Jul 11. Blood. 2012. PMID: 22786876 Free article.
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.
Creutzig U, van den Heuvel-Eibrink MM, Gibson B, Dworzak MN, Adachi S, de Bont E, Harbott J, Hasle H, Johnston D, Kinoshita A, Lehrnbecher T, Leverger G, Mejstrikova E, Meshinchi S, Pession A, Raimondi SC, Sung L, Stary J, Zwaan CM, Kaspers GJ, Reinhardt D; AML Committee of the International BFM Study Group. Creutzig U, et al. Among authors: reinhardt d. Blood. 2012 Oct 18;120(16):3187-205. doi: 10.1182/blood-2012-03-362608. Epub 2012 Aug 9. Blood. 2012. PMID: 22879540 Free article. Review.
Mapping epigenetic regulator gene mutations in cytogenetically normal pediatric acute myeloid leukemia.
Valerio DG, Katsman-Kuipers JE, Jansen JH, Verboon LJ, de Haas V, Stary J, Baruchel A, Zimmermann M, Pieters R, Reinhardt D, van den Heuvel-Eibrink MM, Zwaan CM. Valerio DG, et al. Among authors: reinhardt d. Haematologica. 2014 Aug;99(8):e130-2. doi: 10.3324/haematol.2013.094565. Epub 2014 May 9. Haematologica. 2014. PMID: 24816242 Free PMC article. No abstract available.
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.
de Rooij JD, Masetti R, van den Heuvel-Eibrink MM, Cayuela JM, Trka J, Reinhardt D, Rasche M, Sonneveld E, Alonzo TA, Fornerod M, Zimmermann M, Pigazzi M, Pieters R, Meshinchi S, Zwaan CM, Locatelli F. de Rooij JD, et al. Among authors: reinhardt d. Blood. 2016 Jun 30;127(26):3424-30. doi: 10.1182/blood-2016-01-695551. Epub 2016 Apr 25. Blood. 2016. PMID: 27114462 Free PMC article.
Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.
Noort S, Zimmermann M, Reinhardt D, Cuccuini W, Pigazzi M, Smith J, Ries RE, Alonzo TA, Hirsch B, Tomizawa D, Locatelli F, Gruber TA, Raimondi S, Sonneveld E, Cheuk DK, Dworzak M, Stary J, Abrahamsson J, Arad-Cohen N, Czogala M, De Moerloose B, Hasle H, Meshinchi S, van den Heuvel-Eibrink M, Zwaan CM. Noort S, et al. Among authors: reinhardt d. Blood. 2018 Oct 11;132(15):1584-1592. doi: 10.1182/blood-2018-05-849059. Epub 2018 Aug 27. Blood. 2018. PMID: 30150206 Free PMC article.
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.
Balgobind BV, Van Vlierberghe P, van den Ouweland AM, Beverloo HB, Terlouw-Kromosoeto JN, van Wering ER, Reinhardt D, Horstmann M, Kaspers GJ, Pieters R, Zwaan CM, Van den Heuvel-Eibrink MM, Meijerink JP. Balgobind BV, et al. Among authors: reinhardt d. Blood. 2008 Apr 15;111(8):4322-8. doi: 10.1182/blood-2007-06-095075. Epub 2008 Jan 2. Blood. 2008. PMID: 18172006 Free article.
Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia.
de Rooij JD, Beuling E, van den Heuvel-Eibrink MM, Obulkasim A, Baruchel A, Trka J, Reinhardt D, Sonneveld E, Gibson BE, Pieters R, Zimmermann M, Zwaan CM, Fornerod M. de Rooij JD, et al. Among authors: reinhardt d. Haematologica. 2015 Sep;100(9):1151-9. doi: 10.3324/haematol.2015.124321. Epub 2015 Jun 11. Haematologica. 2015. PMID: 26069293 Free PMC article. Clinical Trial.
908 results